CA2119571A1 - Retinoids and their use in treating skin diseases and leukemia - Google Patents

Retinoids and their use in treating skin diseases and leukemia

Info

Publication number
CA2119571A1
CA2119571A1 CA002119571A CA2119571A CA2119571A1 CA 2119571 A1 CA2119571 A1 CA 2119571A1 CA 002119571 A CA002119571 A CA 002119571A CA 2119571 A CA2119571 A CA 2119571A CA 2119571 A1 CA2119571 A1 CA 2119571A1
Authority
CA
Canada
Prior art keywords
alkyl
compound
formula
acid
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002119571A
Other languages
English (en)
French (fr)
Inventor
Reinhard Sarges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2119571A1 publication Critical patent/CA2119571A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/80—Phthalic acid esters
    • C07C69/82—Terephthalic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/86—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002119571A 1991-09-24 1992-08-10 Retinoids and their use in treating skin diseases and leukemia Abandoned CA2119571A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76457891A 1991-09-24 1991-09-24
US764,578 1991-09-24

Publications (1)

Publication Number Publication Date
CA2119571A1 true CA2119571A1 (en) 1993-04-01

Family

ID=25071126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002119571A Abandoned CA2119571A1 (en) 1991-09-24 1992-08-10 Retinoids and their use in treating skin diseases and leukemia

Country Status (6)

Country Link
EP (1) EP0642499A1 (pt)
JP (1) JPH06507178A (pt)
CA (1) CA2119571A1 (pt)
FI (1) FI941345A0 (pt)
PT (1) PT100878A (pt)
WO (1) WO1993006086A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420145A (en) * 1993-03-22 1995-05-30 Koichi Shudo Carboxylic acid derivative
ATE195716T1 (de) * 1992-04-22 2000-09-15 Ligand Pharm Inc Retinoid-x rezeptor selektive verbindungen
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
CA2137997A1 (en) * 1994-01-03 1995-07-04 John E. Starrett, Jr. Retinoid-like compounds
US5648385A (en) * 1994-01-03 1997-07-15 Bristol-Myers Squibb Co. Retinoid-like compounds
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5559248A (en) * 1995-04-05 1996-09-24 Bristol-Myers Squibb Co. Retinoid-like heterocycles
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5726191A (en) * 1995-11-16 1998-03-10 Hoffmann-La Roche Inc. Aromatic carboxylic acid esters
WO2000063196A1 (en) * 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
WO2022140467A1 (en) * 2020-12-21 2022-06-30 Samson Pharma, Llc Topical compositions and methods of treating skin diseases and conditions with such compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
EP0435222A3 (en) * 1989-12-27 1991-12-11 Hoechst-Roussel Pharmaceuticals Incorporated Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
EP0642499A1 (en) 1995-03-15
PT100878A (pt) 1993-10-29
FI941345A (fi) 1994-03-23
JPH06507178A (ja) 1994-08-11
WO1993006086A1 (en) 1993-04-01
FI941345A0 (fi) 1994-03-23

Similar Documents

Publication Publication Date Title
RU2191009C2 (ru) СПОСОБЫ ЛЕЧЕНИЯ ПРИ ПОМОЩИ СОЕДИНЕНИЙ, ОБЛАДАЮЩИХ СПЕЦИФИЧНОЙ ИЛИ СЕЛЕКТИВНОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К РЕЦЕПТОРУ РЕТИНОВОЙ КИСЛОТЫ (PPKα)
DK172070B1 (da) Benzonaphthalen-derivater, fremgangsmåde til deres fremstilling og deres anvendelse samt framaceutiske og kosmetiske præparater deraf
KR100450498B1 (ko) 레티노이드형생리활성을갖는치환아릴헤테로아릴라미드
JP3197011B2 (ja) ジ芳香族化合物、ならびに人間および動物用医薬ならびに化粧品におけるそれらの用途
JP2548176B2 (ja) ベンゾピラニルおよびベンゾチオピラニルベンゼン化合物、その製法並びに化粧品とひと・動物薬
AU597329B2 (en) Benzamido-aromatic derivatives, process for their preparation and their use in human or veterinary medicine and in cosmetics
EP0920312B1 (en) Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
US4876381A (en) Naphthalene derivatives possessing a retinoid-type action, processes for their preparation, and medicinal and cosmetic compositions containing these derivatives
CA2119571A1 (en) Retinoids and their use in treating skin diseases and leukemia
HU220240B (hu) Retionidok alkalmazása kozmetikai készítményekben vagy gyógyászati készítmények előállítására
JP2733054B2 (ja) バイアロマティック化合物および該化合物を含有する薬用および化粧用組成物並びにその使用
JP2003521513A (ja) 抗癌剤としてのアダマンチル誘導体
JPH06509558A (ja) 新規な芳香族多環式化合物及びヒト又は動物用医薬及び化粧料におけるそれらの使用
JPH0255430B2 (pt)
JP3244271B2 (ja) サリチル単位から誘導された新規二芳香族化合物、その製法ならびにヒトおよび動物医薬ならびに化粧品におけるその使用
JPS62221681A (ja) 新規ベンゾフラン誘導体とその製造方法ならびにこれを含有する医薬および化粧品組成物
JP2634394B2 (ja) ５，８，１１−エイコサトリイン酸の製造方法
JPH08301760A (ja) 皮膚外用剤
JPH11507960A (ja) 二環式芳香族化合物、これらを含有する組成物及びその使用
JP3282630B2 (ja) ベンズイミダゾール誘導体化合物、その製造方法及びその化粧料用途
KR20040000638A (ko) 히드록시 피라논 유도체 및 이의 제조방법
US5332856A (en) Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
RU2185373C2 (ru) Биароматические соединения и фармацевтическая и косметическая композиции на их основе
US4892940A (en) Aromatic naphthyl compounds, a process for their preparation and their use in human and veterinary medicine and in cosmetic compositions
JP2002518371A (ja) ジアリールセレン化物化合物、並びにヒト又は動物の医薬及び化粧品における使用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead